Additionally, elevated expression of immune checkpoint genes (e.g., PDCD1 and CTLA-4) in the high MDK-NCL group suggests that this pathway might promote immune evasion by enhancing the tumor’s dependence on checkpoint mechanisms. The gene discussed is PDCD1; the disease is neoplasm.